Publications

Journal Articles

  1. Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6. PLoS ONE 9(2), e90338
  2. & Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma. Journal of Cellular and Molecular Medicine 17(3), 356-364.
  3. & Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma. Journal of Cellular and Molecular Medicine 17, 356-364.
  4. & Identification of small interfering RNA targeting signal transducer and activator of transcription-6: characterisation and selection of candidates for pre-clinical development. J. RNAi Gene Silencing 6, 401-10.
  5. & RNA interference of STAT6 rapidly attenuates ongoing interleukin-13-mediated events in lung epithelial cells. Immunology 127, 256-266.
  6. Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. Journal of Medical Genetics 41(7), 535-539.
  7. & Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology 111(3), 298-305.
  8. & An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. European Journal of Immunology 32(10), 2923-2933.
  9. & Sex-Associated Hormones and Immunity to Protozoan Parasites. Clinical Microbiology Reviews 14(3), 476-488.